OPEN END TURBO OPTIONSSCHEIN SHORT - QUEST DIAGNOSTICS | Market Closed - BOERSE MUENCHEN 19:25:33 09/05/2024 BST | ||
| 0.59 EUR | -13.24% |
|
| Current month | +28.82% | ||
| 1 month | -45.37% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about QUEST DIAGNOSTICS INCORPORATED
More news
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/05/24 | 0.59 | -13.24% | 0 |
| 08/05/24 | 0.68 | -8.11% | 0 |
| 07/05/24 | 0.74 | +8.82% | 0 |
| 06/05/24 | 0.68 | -5.56% | 0 |
| 03/05/24 | 0.72 | -1.37% | 0 |
Real-time BOERSE MUENCHEN
Last update May 09, 2024 at 07:25 pm
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | QUEST DIAGNOSTICS INCORPORATED |
| Issuer | Goldman Sachs |
| WKN | GQ4ADY |
| ISIN | DE000GQ4ADY9 |
| Date issued | 01/09/2023 |
| Strike | 143.2 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 1.25 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 2.43 € |
|---|---|
| Lowest since issue | 0.21 € |
Company Profile
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows:
- testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services;
- other (2.7%).
Sector
-
Ratings for Quest Diagnostics Incorporated
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Quest Diagnostics Incorporated
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
138.2
USD
Average target price
146.7
USD
Spread / Average Target
+6.21%
- Stock Market
- Certificates
- Certificat
